Pharmaceutical giant Pfizer to combine with Mylan

Pharmaceutical giant Pfizer to combine with Mylan

Pfizer is buying Mylan in an all-stock deal and combining the $10bn generic pharmaceutical company with its own off-patent branded and generic business.

The Pfizer business, called Upjohn, makes Lipitor, Celebrex and Viagra.

Mylan, based just outside of Pittsburgh, is best known for its EpiPen, an injector used to halt life-threatening allergic reactions.

Pfizer shareholders will own 57% of the combined new company and Mylan shareholders will own 43%.

The deal today arrives at a precarious time for big drugmakers who are threatened by patent protection losses and lower-priced rivals.

The new company will be incorporated in Delaware, US and run operations in Pittsburgh, Shanghai and Hyderabad, India.

The combination is expected to close in the middle of next year.

- Associated Press

More in this Section

Activists block main entrance to Frankfurt motor showActivists block main entrance to Frankfurt motor show

Attacks on Saudi oil facilities ‘knocked out roughly half of supply’Attacks on Saudi oil facilities ‘knocked out roughly half of supply’

Germany claims it's not set for recessionGermany claims it's not set for recession

Soccer club’s petition grantedSoccer club’s petition granted


Lifestyle

The evening may have gotten off to a slow start, but velvet-voiced Canadian singer-songwriter Feist’s performance at Cork Opera House on Saturday night was worth waiting for.Velvet-voiced Feist worth the wait

More From The Irish Examiner